ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Engerix-B 10, Injektionssuspension - 
00551004 GlaxoSmithKline AG
Engerix-B 10, Injektionssuspension04.10.1989
  01.05.2002
Hepatitis B, Purified Antigen (J07BC01) 
WHO-DDD 
08.08. 
08.08. 
B  
No 
IP 
PR  
k.A.PR
  
7680005510044Impfstoffe
  
Composition
hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.25 mg ut aluminii hydroxidum, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.75 mg.
Packungsbestandteile
Injection suspension
 
 
Active AgentDose
Hepatitidis b viri Antigenum Adnr10µg / 0.5ml
 
Inactive agentsDose
Alumine0.25mg / 0.5ml
Disodium Phosphate Dihydrate 
Sodium Chloride 
Sodium Dihydrogenophosphate Dihydrate 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home